Medindia
Medindia LOGIN REGISTER
Advertisement

Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Monday, March 4, 2019 General News
Advertisement
Merck's CRISPR patent in Canada covers foundational genome-editing technology that improves CRISPR’s ability to fix diseased genes while not affecting healthy ones
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close